Medicines Australia represents the research-based pharmaceutical industry of Australia. Our members discover, develop and manufacture the medicines and vaccines that are the foundation of a healthy and prosperous society.
Reforming Australia’s Health Technology Assessment (HTA) system
Medicines Australia is driving the reform of our HTA system through our Strategic Agreement with the Commonwealth. This once-in-a-generation opportunity is a critical step to improving our Pharmaceutical Benefits Scheme to give Australians faster access to new treatments.
Strategic Agreement
Medicines Australia has secured a 5-year Strategic Agreement with the Federal Government, centered on earlier patient involvement and influence in the availability of new medicines in Australia.
Strengthening Australia’s clinical trials ecosystem
Australia plays a vital role in the research and development of new medicines through clinical trials. Medicines Australia partners with stakeholders to ensure Australia remains globally competitive as a research and development destination.
Code of Conduct
Medicines Australia sets a standard that ensures the Australian pharmaceutical industry acts with integrity and honesty to improve patient care. The Code of Conduct supports the Therapeutic Goods Act and regulates how industry communicates about prescription medicines.
Industry highlights
Latest submissions
Medicines Australia helps to shape policy outcomes by participating in consultations, reviews and surveys on matters that impact Australia’s pharmaceutical industry.
View our latest submissions >>
Newsroom
